Pharma Sessions
Episodes
58 episodes
The Question Behind the Question - Field Training with Jennifer Muszik
What separates a good pharma sales rep from a great one? According to Jennifer Muszik, it's the ability to understand the question behind the question — the real need behind what a customer is asking.In this episode, Jonathan Kaskey sits...
.png)
Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Frank Sorce, Chief Commercial Officer at UPM Pharmaceuticals, to share insights into the critical decisions involved in selecting contract development and manufacturing organ...
Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. Simon Chowdhury, a Consultant Medical Oncologist based at Guy's and St Thomas' NHS Foundation Trust, to talk about Open Medicine, a platform designed to take what’s insid...
.png)
Timothy Smith on AI, Data, and Drug Discovery at Takeda
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Timothy Smith, Senior Director of AI Innovation and Head of the Data Sciences Communities at Takeda, to explore how AI is transforming drug discovery and development, why trust ...
Lessons on Leading Through Uncertainty in Pharma
In this episode of Pharma Sessions, host Jonathan Kaskey welcomes back Danie du Plessis, the first-ever guest on Pharma Sessions, for a wide-ranging conversation about what it takes to lead in medical affairs today. Pharma Sessions provides gener...
Where AI Delivers Real Value in Pharma Today with Emily Lewis
Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity. In this episod...
How Medical Affairs Becomes the Connector with Sonia Talwar
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve...
Why Manufacturing Is the New Competitive Edge in Cell and Gene Therapy
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cel...
The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2
In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-ba...
The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 1
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current ...
How AI Is Reshaping Pharma’s Commercial Operations with Punit Kumar
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Punit Kumar, the Executive Director of Customer Engagement for the US Enterprise Portfolio at Novartis, to dive into why execution excellence matters more than hype, how AI agen...
Why Pharma products win or lose years before launch
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Farrell Simon, Chief Commercial Officer at Trevi Therapeutics, to discuss what commercial leadership looks like long before launch, sharing lessons from a career that spans Proc...
Building a Cancer Medtech Company the Hard Way: Shaun Bagai on Evidence, Strategy, and Growth
Drug launches in oncology don’t succeed simply because the technology works; they succeed when the evidence is strong enough to change physician behavior. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Shaun Bagai, CEO of Re...
How to Actually Get the Stuff You Want Approved in Pharma
In this solo episode of Pharma Sessions, host Jonathan Kaskey breaks down what actually determines whether a new technology implementation in pharma succeeds or quietly dies in a steering committee meeting. After helping pharma companies implement...
How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko
Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Phar...
Why Drug Launches Are Won Years Before Approval with Ana Bozas
Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Phar...
Building AI Workflows That Actually Work in Pharma with Adam Mico
Generative AI is changing analytics in pharma, but not in the way most people fear. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Adam Mico, Principal Data and Analytics Strategist at Moderna, to dive into what future-proof...
Why AI Pilots Fail in Pharma, And Why Yours Won’t with Jeremy Zhang
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jeremy Zhang, Senior Director and Head of Data Science Solutions at Otsuka, to discuss why AI initiatives succeed or fail in pharma and why it has almost nothing to do with the ...
Medical Affairs AI & Omnichannel Strategy: How to Earn Trust and Attention
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sean Sheffler-Collins, Director of Scientific Communications and Content at Astellas Pharma, to discuss how Medical Affairs is evolving to meet HCPs' needs through omnichannel c...
Sales Leadership Mastery: People + Tech
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Trevor Landry, the Executive Director of CNS Sales at Otsuka, to unpack how commercial leaders can use data and AI without losing the on-the-ground realities that drive great se...
Scientific Storytelling and Omnichannel Strategy in Modern Medical Affairs
In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Matthew Krzywosz, Director of Scientific Communications & Content at Astellas, to explore how Medical Affairs teams can create differentiated scientific narratives, use omnich...
New Direction: Career Pivots, Niche AI, and the Future of Pharma Sessions
In this special episode of Pharma Sessions, host Jonathan Kaskey steps behind the mic solo to share the evolving vision for the podcast and the personal career shift that inspired it. What began as a show centered on medical affairs is now broaden...
Martin McLaughlin’s Four-Pillar Playbook to Launching Better, Faster, and Smarter
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performan...
What Happens When Pharma Starts Listening?
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jens Øllgaard, Head of Customer Experience at Novo Nordisk, to discuss how forward-thinking pharma leaders are dismantling silos between medical and commercial teams, leveraging...
How Shionogi's VP Turns Data into Commercial Success
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Anindita (Ani) Sinha, Vice President of Commercial Operations at Shionogi, to unpack practical approaches to drive market success, from translating complex data into actionable ...
